Announcements Trials
Browse Landscape

Phase

Phase 2 77Phase 1 71Phase 1/2 30Phase 3 14Phase NA 4Phase EARLY_PHASE1 2Phase 2/3 2Phase 4 1

Status

Unknown 7Recruiting 5Completed 4Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 2Thoracic 1Plasma cell 1

Conditions

Multiple Myeloma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Carcinoma, Non-Small-Cell Lung 1Carcinogenesis 1

Interventions

Exercise 216Blood Specimen Collection 122Surveys and Questionnaires 117Standard of Care 114Magnetic Resonance Spectroscopy 113Early Intervention, Educational 108Educational Status 102Methods 101Radiotherapy 94Radiosurgery 76Counseling 72Control Groups 64Biopsy 61Acupuncture Therapy 60Therapeutics 57Psychiatric Rehabilitation 55Resistance Training 52Saline Solution 49Cyclophosphamide 48Palliative Care 46Practice Guidelines as Topic 41Cognitive Behavioral Therapy 41Yoga 40Metformin 40Interviews as Topic 40Drug Therapy 37Surgical Procedures, Operative 36Radiofrequency Ablation 35Dexmedetomidine 35Colonoscopy 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Completed × Azacitidine × Clear all
NCT05471700 2025-09-23

Single Arm Study of Azacitidine and Venetoclax for Treatment of Newly Diagnosed Fit Acute Myeloid Leukemia Patients

Zhujiang Hospital

Phase NA Completed
40 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01050790 2018-06-26

Lenalidomide + Azacitidine for Adaptive Immunotherapy -> Auto SCT in Multiple Myeloma

Virginia Commonwealth University

Phase NA Completed
17 enrolled 14 charts
Plasma cell

Multiple Myeloma

NCT01209520 2015-02-24

Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy

University of Miami

Phase NA Completed
6 enrolled 6 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinogenesis

NCT00660400 2014-09-22

Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrome Who Are Candidates For Allogeneic Hematopoietic Cell Transplant

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
25 enrolled 9 charts
Other hematologic neoplasm

Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡